Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast, Price & News

Wall Street analysts have given Virtus LifeSci Biotech Clinical Trials ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Virtus LifeSci Biotech Clinical Trials ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Virtus LifeSci Biotech Clinical Trials ETF's stock was trading at $30.11 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BBC shares have increased by 57.2% and is now trading at $47.32.
View which stocks have been most impacted by COVID-19.

Based on aggregate information from My MarketBeat watchlists, some companies that other Virtus LifeSci Biotech Clinical Trials ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), (SNY), Intel (INTC), Pfizer (PFE), Simon Property Group (SPG), Cisco Systems (CSCO), Micron Technology (MU), Alibaba Group (BABA) and Johnson & Johnson (JNJ).

Virtus LifeSci Biotech Clinical Trials ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "BBC."

Virtus LifeSci Biotech Clinical Trials ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Flow Traders U.S. LLC (1.23%).
View institutional ownership trends for Virtus LifeSci Biotech Clinical Trials ETF.

BBC stock was acquired by a variety of institutional investors in the last quarter, including Flow Traders U.S. LLC.
View insider buying and selling activity for Virtus LifeSci Biotech Clinical Trials ETF or or view top insider-buying stocks.

Shares of BBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BBC stock can currently be purchased for approximately $47.32.

Virtus LifeSci Biotech Clinical Trials ETF has a market capitalization of $40.22 million.